These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12358253)

  • 1. Suspected inflammatory bowel disease--the clinical and economic impact of competing diagnostic strategies.
    Dubinsky MC; Johanson JF; Seidman EG; Ofman JJ
    Am J Gastroenterol; 2002 Sep; 97(9):2333-42. PubMed ID: 12358253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of serodiagnostic testing in suspected pediatric inflammatory bowel disease.
    Dubinsky MC; Ofman JJ; Urman M; Targan SR; Seidman EG
    Am J Gastroenterol; 2001 Mar; 96(3):758-65. PubMed ID: 11280547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of diagnostic testing strategies for Helicobacter pylori.
    Vakil N; Rhew D; Soll A; Ofman JJ
    Am J Gastroenterol; 2000 Jul; 95(7):1691-8. PubMed ID: 10925969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine.
    Dubinsky MC; Reyes E; Ofman J; Chiou CF; Wade S; Sandborn WJ
    Am J Gastroenterol; 2005 Oct; 100(10):2239-47. PubMed ID: 16181376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine.
    Marra CA; Esdaile JM; Anis AH
    J Rheumatol; 2002 Dec; 29(12):2507-12. PubMed ID: 12465143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of various strategies in the diagnostic management of pulmonary embolism.
    Oudkerk M; van Beek EJ; van Putten WL; Büller HR
    Arch Intern Med; 1993 Apr; 153(8):947-54. PubMed ID: 8481067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness analysis of diagnostic strategies for symptomatic patients with ileal pouch-anal anastomosis.
    Shen B; Shermock KM; Fazio VW; Achkar JP; Brzezinski A; Bevins CL; Bambrick ML; Remzi FH; Lashner BA
    Am J Gastroenterol; 2003 Nov; 98(11):2460-7. PubMed ID: 14638349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost implications of selective preoperative risk screening in the care of candidates for peripheral vascular operations.
    Shaw LJ; Hachamovitch R; Cohen M; Berman DS; Borges-Neto S; Udelson JE; Heller GV; Eisenstein EL; Eagle KA; Hendel RC; Miller DD
    Am J Manag Care; 1997 Dec; 3(12):1817-27. PubMed ID: 10178472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of alternative strategies for tuberculosis screening before kindergarten entry.
    Flaherman VJ; Porco TC; Marseille E; Royce SE
    Pediatrics; 2007 Jul; 120(1):90-9. PubMed ID: 17606566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies.
    Clark TJ; Barton PM; Coomarasamy A; Gupta JK; Khan KS
    BJOG; 2006 May; 113(5):502-10. PubMed ID: 16637894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost effectiveness of a test to detect metastases for endometrial cancer.
    Havrilesky LJ; Maxwell GL; Chan JK; Myers ER
    Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Costs of ambulant care for patients with inflammatory bowel disease in general practice].
    Beiche A; König HH; Ebinger M; Matysiak-Klose D; Braun V; Leidl R
    Z Gastroenterol; 2003 Jun; 41(6):527-36. PubMed ID: 12806538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing complications from nonsteroidal antiinflammatory drugs: cost-effectiveness of competing strategies in varying risk groups.
    Spiegel BM; Chiou CF; Ofman JJ
    Arthritis Rheum; 2005 Apr; 53(2):185-97. PubMed ID: 15818647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus.
    Gerson L; Lin OS
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):319-25. PubMed ID: 17368231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness analysis of management strategies for obscure GI bleeding.
    Gerson L; Kamal A
    Gastrointest Endosc; 2008 Nov; 68(5):920-36. PubMed ID: 18407270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision and cost analysis in acoustic neuroma diagnosis.
    Bance ML; Hyde ML; Malizia K
    J Otolaryngol; 1994 Apr; 23(2):109-20. PubMed ID: 8028068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dyspepsia and functional gastrointestinal disorders: a cost-benefit analysis of different approaches.
    Sonnenberg A; Townsend WF; Müller AD
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):655-9. PubMed ID: 8590161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruling out IBD: estimation of the possible economic effects of pre-endoscopic screening with F-calprotectin.
    Mindemark M; Larsson A
    Clin Biochem; 2012 May; 45(7-8):552-5. PubMed ID: 22056737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopic outcomes analysis.
    Olson AD; Fendrick AM; Deutsch DE
    Gastrointest Endosc Clin N Am; 2001 Oct; 11(4):557-68, v. PubMed ID: 11689356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Decision analysis and initiation of an "empiric" therapy].
    Van Meerhaeghe A
    Rev Med Brux; 1999 Feb; 20(1):21-4. PubMed ID: 10091532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.